You are using an older browser version. Please use a supported version for the best MSN experience.

FDA Advisory Committee Member discusses future of Johnson & Johnson vaccine

Federal agencies are expected to decide whether the Johnson & Johnson covid-19 vaccine can resume this week. Member of the FDA Vaccine Advisory Committee Dr. Paul Offit weighs in on the vaccine's fate and explains its advantages, but cautions it now has a "scarlet letter" on it.

UP NEXT

UP NEXT

More From MSNBC

More From MSNBC

image beaconimage beaconimage beacon